# Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult

> **NCT06285136** · PHASE2,PHASE3 · UNKNOWN · sponsor: **The Second Affiliated Hospital of Kunming Medical University** · enrollment: 40 (estimated)

## Conditions studied

- Acute Myeloid Leukemia, Adult

## Interventions

- **PROCEDURE:** DEC3-VEN

## Key facts

- **NCT ID:** NCT06285136
- **Lead sponsor:** The Second Affiliated Hospital of Kunming Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-02-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06285136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06285136, "Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06285136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*